Literature DB >> 14691222

Differences in aggregation properties of three site-specific mutants of recombinant human stefin B.

Manca Kenig1, Selma Berbić, Aida Krijestorac, Louise Kroon-Zitko, Magda Tusek, Marusa Pompe-Novak, Eva Zerovnik.   

Abstract

We describe expression, purification, and characterization of three site-specific mutants of recombinant human stefin B: H75W, P36G, and P79S. The far- and near-UV CD spectra have shown that they have similar secondary and tertiary structures to the parent protein. The elution on gel-filtration suggests that recombinant human stefin B and the P36G variant are predominantly monomers, whereas the P79S variant is a dimer. ANS dye binding, reflecting exposed hydrophobic patches, is highest for the P36G variant, both at pH 5 and 3. ANS dye binding also is increased for stefin B and the other two variants at pH 3. Under the chosen conditions the highest tendency to form amyloid fibrils has been shown for the recombinant human stefin B. The P79S variant demonstrates a longer lag phase and a lower rate of fibril formation, while the P36G variant is most prone to amorphous aggregation. This was demonstrated by ThT fluorescence as a function of time and by transmission electron microscopy.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14691222      PMCID: PMC2286520          DOI: 10.1110/ps.03270904

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  38 in total

1.  Accessing the global minimum conformation of stefin A dimer by annealing under partially denaturing conditions.

Authors:  R Jerala; E Zerovnik
Journal:  J Mol Biol       Date:  1999-09-03       Impact factor: 5.469

2.  Differences in the effects of TFE on the folding pathways of human stefins A and B.

Authors:  E Zerovnik; R Virden; R Jerala; L Kroon-Zitko; V Turk; J P Waltho
Journal:  Proteins       Date:  1999-08-01

3.  Calorimetric measurements of thermal denaturation of stefins A and B. Comparison to predicted thermodynamics of stefin-B unfolding.

Authors:  E Zerovnik; K Lohner; R Jerala; P Laggner; V Turk
Journal:  Eur J Biochem       Date:  1992-11-15

Review 4.  The cystatins: protein inhibitors of cysteine proteinases.

Authors:  V Turk; W Bode
Journal:  FEBS Lett       Date:  1991-07-22       Impact factor: 4.124

5.  Intermediates in denaturation of a small globular protein, recombinant human stefin B.

Authors:  E Zerovnik; R Jerala; L Kroon-Zitko; R H Pain; V Turk
Journal:  J Biol Chem       Date:  1992-05-05       Impact factor: 5.157

6.  On the mechanism of human stefin B folding: I. Comparison to homologous stefin A. Influence of pH and trifluoroethanol on the fast and slow folding phases.

Authors:  E Zerovnik; R Virden; R Jerala; V Turk; J P Waltho
Journal:  Proteins       Date:  1998-08-15

7.  Progressive ataxia, myoclonic epilepsy and cerebellar apoptosis in cystatin B-deficient mice.

Authors:  L A Pennacchio; D M Bouley; K M Higgins; M P Scott; J L Noebels; R M Myers
Journal:  Nat Genet       Date:  1998-11       Impact factor: 38.330

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

9.  Theoretical study of the contribution of aromatic side chains to the circular dichroism of basic bovine pancreatic trypsin inhibitor.

Authors:  M C Manning; R W Woody
Journal:  Biochemistry       Date:  1989-10-17       Impact factor: 3.162

10.  The refined 2.4 A X-ray crystal structure of recombinant human stefin B in complex with the cysteine proteinase papain: a novel type of proteinase inhibitor interaction.

Authors:  M T Stubbs; B Laber; W Bode; R Huber; R Jerala; B Lenarcic; V Turk
Journal:  EMBO J       Date:  1990-06       Impact factor: 11.598

View more
  7 in total

1.  In vitro study of stability and amyloid-fibril formation of two mutants of human stefin B (cystatin B) occurring in patients with EPM1.

Authors:  Sabina Rabzelj; Vito Turk; Eva Zerovnik
Journal:  Protein Sci       Date:  2005-09-09       Impact factor: 6.725

2.  Human stefin B normal and patho-physiological role: molecular and cellular aspects of amyloid-type aggregation of certain EPM1 mutants.

Authors:  Mira Polajnar; Slavko Ceru; Nataša Kopitar-Jerala; Eva Zerovnik
Journal:  Front Mol Neurosci       Date:  2012-08-24       Impact factor: 5.639

3.  The role of initial oligomers in amyloid fibril formation by human stefin B.

Authors:  Ajda Taler-Verčič; Tiina Kirsipuu; Merlin Friedemann; Andra Noormägi; Mira Polajnar; Julia Smirnova; Magda Tušek Znidarič; Matjaž Zganec; Miha Skarabot; Andrej Vilfan; Rosemary A Staniforth; Peep Palumaa; Eva Zerovnik
Journal:  Int J Mol Sci       Date:  2013-09-05       Impact factor: 5.923

4.  Proline Residues as Switches in Conformational Changes Leading to Amyloid Fibril Formation.

Authors:  Ajda Taler-Verčič; Samra Hasanbašić; Selma Berbić; Veronika Stoka; Dušan Turk; Eva Žerovnik
Journal:  Int J Mol Sci       Date:  2017-03-07       Impact factor: 5.923

5.  Prolines Affect the Nucleation Phase of Amyloid Fibrillation Reaction; Mutational Analysis of Human Stefin B.

Authors:  Samra Hasanbašić; Ajda Taler-Verčič; Vida Puizdar; Veronika Stoka; Magda Tušek Žnidarič; Andrej Vilfan; Selma Berbić; Eva Žerovnik
Journal:  ACS Chem Neurosci       Date:  2019-04-09       Impact factor: 4.418

6.  Protein aggregation and protein instability govern familial amyotrophic lateral sclerosis patient survival.

Authors:  Qi Wang; Joshua L Johnson; Nathalie Y R Agar; Jeffrey N Agar
Journal:  PLoS Biol       Date:  2008-07-29       Impact factor: 8.029

7.  Structural characterization of semen coagulum-derived SEM1(86-107) amyloid fibrils that enhance HIV-1 infection.

Authors:  Kinsley C French; Nadia R Roan; George I Makhatadze
Journal:  Biochemistry       Date:  2014-05-12       Impact factor: 3.162

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.